Acrivon Therapeutics, Inc. Property, Plant and Equipment
Acrivon Therapeutics, Inc. (ACRV) had Property, Plant and Equipment of $4.25 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-12
- 2026-06-30: Property, Plant and Equipment, Net $4.25M.
- 2026-03-31: Property, Plant and Equipment, Net $4.65M.
- 2025-12-31: Property, Plant and Equipment, Net $4.89M.
- 2025-09-30: Property, Plant and Equipment, Net $5.19M.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2026-06-30 | $4.25M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $4.65M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $4.89M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $5.19M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $5.07M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $4.68M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $4.47M 10-K · filed 2026-03-19 |
| 2024-09-30 | $4.67M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $3.47M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $3.41M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $3.48M 10-K · filed 2025-03-27 |
| 2023-09-30 | $2.00M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.98M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $1.99M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.09M 10-K · filed 2024-03-28 |
| 2022-09-30 | $2.15M 10-Q · filed 2022-12-15 |
| 2021-12-31 | $290.00K 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rallybio Corp (RLYB) | United States | $0.089B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |